Product Images Topiramate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Topiramate NDC 43063-735 by Pd-rx Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
43063735 Label - 43063735
This is a description of a medication called Topiramate in the form of 60 white round tablets, each containing USP 25mg. It provides instructions to take the tablet(s) multiple times per day and warns to keep it out of reach of children. It also includes the ReOrder number, LOT, and expiration date. The packaging insert offers dosage and storage instructions. In case of side effects, it is advisable to contact a doctor or the FDA. The remaining text is not legible.*
ccb7a1e4 a3a1 4a0e 8eb0 8086f53e314b 01
ccb7a1e4 a3a1 4a0e 8eb0 8086f53e314b 02
The text appears to show a graph presenting cumulative rates for time to the first seizure for two groups of individuals: one group treated with Topiramate 50 mg/day (N=234) and the other group treated with Topiramate 400 mg/day (N=236). The X-axis represents time in days, ranging from 0 to 500, and the Y-axis represents the cumulative rate of the first seizure.*
ccb7a1e4 a3a1 4a0e 8eb0 8086f53e314b 03
The text indicates the change in the average monthly migraine period rate during a double-blind phase of a study with Topamax. The dosage used in the study was either 100 or 200 milligrams per day. The text also shows significant improvements in the migraine rate, represented by a statistically significant p-value.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.